CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas
VIENNA, Va., June 5 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM ) announced today that its collaborators at the University of Hawaii reported on data at the annual American Society for Microbiology in Philadelphia, PA. This data demonstrates that vaccines utilizing its L.E.A...
Discovery's Edge Spring Issue - http://discoverysedge.mayo.edu
...f us, but to victims of spinal cord injury (SCI) it may be anything but certain. Mayo researchers are exploring ways to ensure breathing capability in sci
Glitches in Ion Transporters -- An Unlikely Link Between Kidney Diseases...
Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
...eatment program in the
Pacific Northwest. A true multidisciplinary program, sci
offers a wide
range of advanced cancer-treatment options in chemotherapy, r...r(TM) at Swedish Medical Center, and
Northwest Hospital Gamma Knife Center. sci
is also working toward adding
the latest generation of proton beam radiothe...
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
...ase issued by the
SEAS investigators today.
Contact: Andrew Trehearne, CTSU, +44(0)1865-743960, +44(0)789-404-2600
Co-directors: Rory Collins FMed sci
FRCP BHF Professor of Medicine and
Epidemiology Sir Richard Peto FRS Hon FRCP Professor of Medical Statistics
Jane Colin ...
Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
...trol of their diaphragms. With the FDA's approval, sci
their caregivers throughout the U.S. ... the clinical trial, NeuRx DPS(TM) provided 98% of sci
had been dependent on mechanical vent...h America by
Stephen P. Burns MD, the incidence of sci
pneumonia for initial admitted
patients was report...
Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
...a Finger Stick Dried Blood Spot Method," by Sanjay
Kapur, PhD, Sonia Kapur, PhD, and David Zava, PhD of ZRT Laboratory,
Beaverton, Oregon, (J Diabetes sci
Technol 2008; 2(2):236-41), describes
ZRT's methods for measurement of insulin, high-sensitivity C-reactive
protein (hs-CRP), and triglycerides from d...
Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
...Ib trial in up to 100
patients with acute cervical sci
at up to 80 sites in the United States,
Canada, Eu...ted countries.
A total of 48 patients with acute sci
were enrolled in the Phase I/IIa
open label study ...ients
who suffered a complete thoracic or cervical sci
(classified as grade A on
the ASIA Impairment Scal...
Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
...ut Spinal Cord Injury, or SCI
There are approximately 11,000 new cases of sci
each year in the U.S.
The average age of injury is 38. The estimated health care costs that are
directly attributable to sci
vary greatly according to severity of the
injury. The National Spinal Cord ...
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008
...first-ever therapeutic option for nerve repair to patients with
acute spinal cord injury, we are committed to the support of the excellent
work of the sci
advocacy groups. These groups reach out to patients,
care-givers, professional societies and the general public providing
valuable educational, qualit...
Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
Phase I/IIa trial in subjects with acute sci
at sites in the United States
and Canada. The trial assessed 5 dose levels ...s in the Cethrin Phase I/IIa
trial suffered a complete thoracic or cervical sci
and were thus classified
as an A on the ASIA Impairment Scale at the time o...
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
...cal trial in acute spinal cord injury (SCI) to
allow subjects with cervical sci
to be treated with a 9 mg dose of
Cethrin(R). This recommendation is based ... FDA. About the Cethrin(R) Phase I/IIa Clinical Trial Patients with acute sci
are enrolled in the open label study at sites
across Canada and the United ...
Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase
I/IIa 6-Month Results at 75th Annual Meeting of the American
Association of Neurological Surgeons
...or early 2008."
Thirty-seven patients with acute sci
were enrolled in the open
label study at nine site...ates. All
patients were classified with a complete sci
assessed as American
Spinal Injury Association (AS...ved to ASIA D.
One patient with a thoracic sci
died from acute respiratory distress
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data
From Nerve Regeneration Program at American Society for Neural
Therapy and Repair Meeting
...od vessel density around the injury. Most
importantly, in a severe model of sci
where animals are paraplegic
post- injury, they observed a statistically si...ed to continue to work with Dr Fehlings who is
world-renown for his work on sci
and has significant clinical trial
experience in this area."
S. Kaye Spra...
New Research Confirms the Benefit of Extended-Release Dipyridamole
Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk
... al. European Stroke Conference, Glasgow, UK, 31 May
2 ESPRIT study group. Lancet 2006; 367(9523): 1665–1673
3 Diener HC, et al. J Neurol sci
1996; 143(1-2): 1–13.
4 Derendorf, H. European Stroke Conference, Glasgow, UK, 30 May
5 Derendorf H, et al. J Clin Pharmacol 2005; 45:
Publication Confirms that EpCAM, the Target for Two of Micromet's
Product Candidates, Is Overexpressed on Cancer Stem Cells of
1 Dalerba P, Dylla SJ, Park I-K et al. Phenotypic characterization of
human colorectal cancer stem cells. Proc Natl Acad sci
2 Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and
expansion of human colon-cancer-initi...
Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for
Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical
...rt at the 13th
Annual Meeting of the International Society for Cellular Therapy,
held here June 24-27. From May 2006 to January 2007, 25 patients
were treated at Luis Vernaza Hospital in Guayaquil,
Ecuador. They were treated with autologous bone marrow stem cells -
meaning the cells were extract...